
Federated Hermes (FHI) stock recently achieved an all-time high of $52.25, reflecting a 63% annual return driven by robust fundamentals, including a 66.6% gross profit margin and 28 consecutive years of dividend payments. The company further reported stronger-than-expected Q2 2025 earnings, with EPS of $1.16 and revenue of $424.84 million, yet its stock price declined post-announcement. Despite this, FHI maintains a "GREAT" overall financial health score from InvestingPro, which suggests the stock may remain slightly undervalued.
Federated Hermes, Inc. (FHI) has demonstrated significant strength, reaching an all-time stock high of $52.25, culminating a 63% annual return. This performance is underpinned by robust fundamentals, including a high gross profit margin of 66.6%, a solid current ratio of 3.37, and an attractive P/E ratio of 11.5x. The company's long-term stability is further evidenced by its 28-year track record of consistent dividend payments. Recent Q2 2025 results surpassed analyst expectations, with EPS at $1.16 against a $1.03 forecast and revenue of $424.84 million exceeding the $422.02 million estimate. Despite these strong earnings and fundamental indicators, which contribute to an overall "GREAT" financial health score from InvestingPro, the stock price experienced a decline following the announcement. This negative market reaction presents a notable disconnect from the positive quantitative data, suggesting investors may be pricing in other factors not explicitly covered in the earnings release.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment